Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Katherine T. Lofgren"'
Autor:
Lee S. Schwartzberg, MD, Gerald Li, PhD, Khaled Tolba, MD, Ariel B. Bourla, MD, PhD, Katja Schulze, PhD, Rujuta Gadgil, MS, Alexander Fine, PhD, Katherine T. Lofgren, PhD, Ryon P. Graf, PhD, Geoffrey R. Oxnard, MD, Davey Daniel, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 9, Pp 100386- (2022)
Introduction: Whereas tumor biopsy is the reference standard for genomic profiling of advanced NSCLC, there are now multiple assays approved by the Food and Drug Administration for liquid biopsy testing of circulating tumor DNA. Here, we study the in
Externí odkaz:
https://doaj.org/article/6ee120b19f7d45749c83a4e3900b99b2
Autor:
Ariel D Stern, PhD, Jan Brönneke, LLM, Jörg F Debatin, MD, Julia Hagen, MPA, Henrik Matthies, PhD, Smit Patel, PharmD, Ieuan Clay, PhD, Bjoern Eskofier, ProfPhD, Annika Herr, ProfPhD, Kurt Hoeller, PhD, Ashley Jaksa, MPH, Daniel B Kramer, MD, Mattias Kyhlstedt, Katherine T Lofgren, PhD, Nirosha Mahendraratnam, PhD, Holger Muehlan, PhD, Simon Reif, PhD, Lars Riedemann, MD, Jennifer C Goldsack, MA
Publikováno v:
The Lancet: Digital Health, Vol 4, Iss 3, Pp e200-e206 (2022)
Summary: In 2019, Germany passed the Digital Healthcare Act, which, among other things, created a “Fast-Track” regulatory and reimbursement pathway for digital health applications in the German market. The pathway explicitly provides for flexibil
Externí odkaz:
https://doaj.org/article/946b756032bc47a5b92f1ed2d9bfbfbd
Autor:
Ami Karlage, Megan Marx Delaney, Lauren Bobanski, Katherine E A Semrau, Amanda Jurczak, Danielle E Tuller, Katherine T Lofgren, Vinay P Singh, Meera Ragavan, Tapan Kalita, Stephen Charles Resch
Publikováno v:
BMJ Open, Vol 12, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/21cb6cc521db4173a029c0e0fbd372f5
Autor:
Bharathi Muthusamy, Kira Raskina, Katherine T. Lofgren, Gerald Li, Khaled Tolba, Karen Schwed, Emily Castellanos, Richard S.P. Huang, Geoffrey R. Oxnard, Alexa B. Schrock, Nathan Pennell
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
Tyrosine kinase inhibitors and immune checkpoint inhibitors (ICI), each requiring testing for precision biomarkers, have recently been approved in the adjuvant setting. We assessed the potential value of multi-gene testing in early lung adenocarcinom
Autor:
Ariel D Stern, Jan Brönneke, Jörg F Debatin, Julia Hagen, Henrik Matthies, Smit Patel, Ieuan Clay, Bjoern Eskofier, Annika Herr, Kurt Hoeller, Ashley Jaksa, Daniel B Kramer, Mattias Kyhlstedt, Katherine T Lofgren, Nirosha Mahendraratnam, Holger Muehlan, Simon Reif, Lars Riedemann, Jennifer C Goldsack
Publikováno v:
The Lancet. Digital health. 4(3)
In 2019, Germany passed the Digital Healthcare Act, which, among other things, created a "Fast-Track" regulatory and reimbursement pathway for digital health applications in the German market. The pathway explicitly provides for flexibility in how re
Autor:
Nathan A. Pennell, Liangliang Zhang, Katherine T Lofgren, Bharathi Muthusamy, Emily Castellanos, Karen Schwed, Olivier Humblet, Alexa Betzig Schrock, Geoffrey R. Oxnard
Publikováno v:
Journal of Clinical Oncology. 40:8525-8525
8525 Background: Resected early-stage NSCLC has high risk of recurrence, and tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICI), each requiring testing for precision biomarkers, have recently been approved in the adjuvant (adj)
Autor:
Stéphane Verguet, David A Watkins, Katherine T. Lofgren, Joshua A. Salomon, Solomon Tessema Memirie
Publikováno v:
Health Economics
Policymakers face difficult choices over which health interventions to publicly finance. We developed an approach to health benefits package design that accommodates explicit tradeoffs between improvements in health and provision of financial risk pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21b736b286dac3d7c320c4f1e6367a0d
https://hdl.handle.net/11250/2989261
https://hdl.handle.net/11250/2989261
Autor:
Daniel M. Sheinson, William B. Wong, Craig S. Meyer, Stella Stergiopoulos, Katherine T. Lofgren, Carlos Flores, Devon V. Adams, Mark E. Fleury
Publikováno v:
JAMA Network Open
Key Points Question Is the implementation of the Medicare national coverage determination (NCD) associated with use of next-generation sequencing by insurance and racial and ethnic categories? Findings In this cohort study of 92 687 patients with lun
Autor:
Katherine T. Lofgren, Mark D. Hornstein, Andrea Lanes, Elizabeth S. Ginsburg, Ann M. Thomas, Malinda Lee, Randi H. Goldman
Publikováno v:
American Journal of Obstetrics and Gynecology. 225:55.e1-55.e17
A controversial and unresolved question in reproductive medicine is the utility of preimplantation genetic testing for aneuploidy as an adjunct to in vitro fertilization. Infertility is prevalent, but its treatment is notoriously expensive and typica
Publikováno v:
American Economic Review. 107:501-505
Maternal and neonatal mortality rates in the slums of Nairobi, Kenya are among the highest in the world. Mounting evidence suggests that delivering in a facility is not enough to ensure mortality reductions: women must deliver in high-quality facilit